Stop TB Partnership calls to quadruple the funding in the fight against TB, as the world is failing the TB response
Experts urge the international community to ensure continuity of TB and health services for war-affected Ukraine.
22 March 2022 I Geneva, Switzerland - Ahead of this year’s World Tuberculosis (TB) Day, marked on 24 March, the Stop TB Partnership called for an urgent and substantial increase of funding to fight TB in order to meet the goal of ending the disease by 2030. The organization’s latest projections show that an average of US$19.6 billion per year will be needed over the next eight years for TB prevention and care, up from the pre-COVID-19 estimate of US$13 billion per year. An additional US$4 billion per year will be required for research and development (R&D) of the new diagnostics, medicines and vaccines needed to end TB. This represents about four times what is currently available for the TB response (in 2020, US$5.3 billion was available for care and prevention and US$0.9 billion for R&D).
The year 2022 is critical for the global fight to end TB as the
world faces a fast-running countdown to reaching the 2018 United
Nations High-Level Meeting (UNHLM) TB targets, which the
international community agreed to meet by the end of December.
All projections show that the world is not on course to meet the
UNHLM treatment targets set for 2022.
“We
simply cannot continue to stand on the sidelines and watch while
people around the world fall ill and die from a preventable and
treatable disease,” said Dr. Lucica Ditiu, Executive
Director of the Stop TB Partnership. “We also cannot
continue to accept what we accepted for years—every year
having less than 40% of the funding need for the TB response.
Now we are facing a disastrous funding shortfall, bigger than
what we had expected. We not only need to step up efforts to
meet targets set at the 2018 UNHLM on TB, but the TB response
must also recover from the devastating impacts of the COVID-19
pandemic.”
The projected increase in the funding needed to end TB considers
setbacks caused by the COVID-19 pandemic and related recovery
measures, as well as the impact of years of funding shortfalls.
Such additional funding will enable TB programs around the world
to treat 50 million people with TB, including 3.7 million
children and 2.2 million people with drug-resistant TB. It will
also enable faster R&D, including for new and effective
vaccines, which are essential if we want to end TB by 2030.
Reaching
the joint goal of ending TB is feasible if countries step up
their funding commitments. Countries of the G20, for example,
who represent 50% of the global TB burden, had a collective GDP
of US$66 trillion in 2020, which is projected at US$99 trillion
in 2026. The Stop TB Partnership estimates that mobilizing only
0.01% of this collective GDP would make additional US$6 billion
available per year for the fight against TB now and US$10
billion per year by 2026.
“TB is an infectious
and deadly airborne disease with drug-resistant variants, and it
is in no one’s interest to continue to let it fester
undeterred around the world. Each untreated TB infection can
lead to 15 more infections per year. As we saw in 2020 with
COVID-19, we can mobilize significant amounts of funding in a
short time if people, including world leaders, take the disease
seriously. We don’t demand anything out of the ordinary;
we demand funds to secure access to proper diagnosis and
treatment for all people. It is, after all, a basic human
right,” Dr. Ditiu added.
TB in times of conflict
The new funding estimates come in the context of the ongoing
brutal war in Ukraine, and experts expressed grave concern about
the potentially devastating impacts on health services,
including the TB response in the country and the region. Ukraine
is one of the top 30 high drug-resistant TB burden countries in
the world, with 1 in 3 people having a form of TB that does not
respond to the most potent TB drugs. In 2021, Ukraine diagnosed
and treated 24,000 people with TB, including almost 5,000 people
with multi-drug resistant TB (MDR-TB).
“The
ongoing war is completely unacceptable. We all make tremendous
efforts to have a better, healthier world and we celebrate every
single person with TB treated with success and cured. And we see
now lives being lost in hundreds in a blink. This must
stop,” said Dr Ditiu.
Ukraine has a strong
national TB program, with its supply of TB drugs entirely
financed from its domestic budget, diagnosis and treatment
available to all people in need nationwide and a well-organized
civil society response. While information from the national TB
program indicates that a majority of people with TB are still
receiving the care they need, having been provided with at least
a month’s supply of drugs, some have already been forced
to discontinue treatment due to lack of access to health care
facilities. The situation is volatile, and it is expected to
worsen if more people are unable to renew their prescriptions in
the coming months and if attacks on health workers and health
facilities continue unabated.
“Whenever there
is conflict or war, essential health services and care are
disrupted, with devastating consequences for the health of
affected populations, especially the most vulnerable,”
added Dr. Ditiu. “While attending to people’s
immediate and basic needs is the absolute priority, neglecting
to act on TB now may have grave consequences in the near future.
Interruption of treatment will lead to the further development
of drug resistance, and the movement of populations, the
closeness experienced in shelters and on the roads, and the drop
of immunity will naturally lead to an increase in
infections.”
With the war resulting in
unprecedented numbers of internally displaced people as well as
refugees to neighboring countries, it is critical that TB
services are provided to all those in need, free from stigma and
discrimination.
“TB is very sensitive, and if we broadcast information
about its uncontrolled spread, we will stigmatize people who are
already stigmatized, for people who are already in a very
difficult situation,” said Ms. Yana Terleeva, Head of
Department of TB Programme Coordination, Center for Public
Health of the Ministry of Health of Ukraine. “The issue of
TB stigma is not only in Ukraine, but across Europe, so
let’s focus on ensuring patients know where to go, and
have a desire to continue treatment. They have to be assured
there is a reason to live, that they will go back to Ukraine,
and they have to be healthy to help us rebuild. They need this
optimism, to have this desire to live and continue
life.”
“We urgently need to provide the
support needed to ensure continuity of treatment for people
affected by TB, as well as to equip neighboring countries with
the tools they need for timely diagnosis and treatment of
refugees,” said Dr. Nino Berdzuli, Director of the
Division of Country Health Programmes, WHO.
The Stop
TB Partnership is continuously monitoring and assessing the
situation in Ukraine and is coordinating efforts with partners
to provide seamless supplies of additional TB drugs to Ukraine
if this need arises. They are also assuring that diagnostics and
medicines are reaching the neighboring countries for
uninterrupted TB care of people in need. The organization is
also repurposing existing grants to support immediate emergency
and lifesaving medical needs.
Additional quotes
Ms. Iana Terleeva, Head of Department of TB Programme
Coordination, Center for Public Health of the Ministry of
Health of Ukraine
“Ukraine was always on the forefront of the
fight against TB. We chose the European way of working when it
comes to diagnostic and care, we wanted Ukraine to be free from
TB. We have done everything possible. We commenced European
reforms in this regard, put in place new policies on how to
treat people with TB, and introduced new diagnostic
methodologies. We’ve worked to overcome the stigma and
discrimination that comes with TB. We thought in March that
we’d be implementing innovative TB treatment regimens."
“Last
year, we were working to differentiate between different TB
mutations. Now instead, we are trying to differentiate between
aerial shelling, raids and other military hardware. We are on
the 26th day of the war and Ukraine has to fight on the one side
illnesses like TB, and on the other side the Russian
invasion.”
“Thousands of people are
now without access to their homes or any sort of dwelling, they
are deprived of their dreams and plans for the future. This has
forced many of our patients to look for better opportunities, we
see displaced people within the country, and some of our
patients leave Ukraine to find better opportunities in other
countries. We appeal for the exchange of information about these
patients so we can treat them further. We are working with the
WHO on creating a coordination center so we can exchange
information, so patients know where to continue treatment."
"We
are defending our country from the aggression, while at the same
time providing everything necessary for our patients.”
Ms. Olya Klymenko, TB survivor and co-founder of the
organization TB People Ukraine
“We understand quite clearly that when
the war is over we will begin to rebuild almost from scratch
because the damages to our medical care and our infrastructure
in the country and also the emotional state of our people will
require massive investments. Unfortunately, TB will not be a
priority investment and that is why we need the unified efforts
of our partners to have organizational support to help our
people.”
Prof. Alexandru Rafila, Minister of Health, Romania
“Romania is a country with a
long-border, we share over 600 km with Ukraine, and we have an
important flow of people coming into our country, including more
than 30,000 children, some of them without their parents.
It’s a big challenge for Romanian authorities, but not yet
for health authorities. But it’s possible that in the next
days or weeks, if the stupid war won’t stop, that we will
have to put in place a big effort regarding the health
sector.”
“During this crisis, there
is an advantage because Romania has in place a network of TB
hospitals and TB ambulatory care centers where we can perform
rapid diagnosis and treatment. We already have support from the
Global Fund regarding the acquisition of molecular rapid tests,
and also to procure treatments for regimens regimen similar to
the ones provided in Ukraine.”
Dr. Nino Berdzuli, Director of the Division of Country
Health Programmes, World Health Organization (WHO)
“The COVID pandemic has resulted in
severely disrupted health services in Europe. Multi-drug
resistant TB, HIV/TB co-infection and late diagnosis are
persistent challenges, particularly in Eastern Europe. With the
Russian military offensive, this will take us back in the TB
response to a situation far worse than the COVID pandemic"
“Before
the war Ukraine was the most dynamic country in terms of
government efforts to reform the health system and move towards
universal health coverage. Ukraine has progressive policies and
accelerated transformation of TB services.”
"The
humanitarian crisis as a result of military offensive, and the
largest displacement since 1945 will set us further back in
terms of the TB response and needs. We need to have decisive and
collective action here. First, our need is to provide the
immediate response inside and outside Ukraine. Our teams are
relentlessly working to find short- and medium-term solutions,
making emergency stocks of drugs available for patients.”
Source:
Stop TB Partnership